Education
About Us
Working with TipRanks
Follow Us
AB Science SA (ABSCF)
OTHER OTC:ABSCF
ABSCF Stock Chart & Stats
$1.45
$0.10(12.50%)
At close: 4:00 PM EST
$1.45
$0.10(12.50%)
Day’s Range― - ―
52-Week Range$0.90 - $1.60
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$108.75M
Enterprise Value$104.72M
Total Cash (Recent Filing)$5.03M
Total Debt (Recent Filing)$19.08M
Price to Earnings (P/E)―
Beta-281271.53
Next Earnings
May 06, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding66,184,790
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)-1.98
Price to Sales (P/S)43.83
P/FCF Ratio127.00
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue101.97
Enterprise Value/Gross Profit92.59
Enterprise Value/Ebitda-23.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AB Science SA News
ABSCF FAQ
What was AB Science SA’s price range in the past 12 months?
AB Science SA lowest stock price was $0.90 and its highest was $1.60 in the past 12 months.
What is AB Science SA’s market cap?
AB Science SA’s market cap is $108.75M.
When is AB Science SA’s upcoming earnings report date?
AB Science SA’s upcoming earnings report date is May 06, 2026 which is in 84 days.
How were AB Science SA’s earnings last quarter?
AB Science SA released its earnings results on Oct 10, 2025. The company reported -$0.106 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.106.
Is AB Science SA overvalued?
According to Wall Street analysts AB Science SA’s price is currently Overvalued.
Does AB Science SA pay dividends?
AB Science SA does not currently pay dividends.
What is AB Science SA’s EPS estimate?
AB Science SA’s EPS estimate is -0.08.
How many shares outstanding does AB Science SA have?
AB Science SA has 66,184,790 shares outstanding.
What happened to AB Science SA’s price movement after its last earnings report?
AB Science SA reported an EPS of -$0.106 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AB Science SA?
Currently, no hedge funds are holding shares in ABSCF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AB Science SA
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Technical Analysis
Innate Pharma SA
―
Transgene
―
OSE Immunotherapeutics SA
―
Sensorion SAS
―
ABL Diagnostics SA
―